Robert L McNamara1, Kevin F Kennedy2, David J Cohen3, Deborah B Diercks4, Mauro Moscucci5, Stephen Ramee6, Tracy Y Wang7, Traci Connolly8, John A Spertus3. 1. Yale University School of Medicine, New Haven, Connecticut. Electronic address: robert.mcnamara@yale.edu. 2. Mid America Heart Institute, Kansas City, Missouri. 3. Saint-Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, Missouri. 4. University of Texas Southwestern Medical Center, Dallas, Texas. 5. Sinai Hospital of Baltimore, Baltimore, Maryland; University of Michigan Health System, Ann Arbor, Michigan. 6. Ochsner Medical Center, New Orleans, Louisiana. 7. Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina. 8. American College of Cardiology, Washington, DC.
Abstract
BACKGROUND: As a foundation for quality improvement, assessing clinical outcomes across hospitals requires appropriate risk adjustment to account for differences in patient case mix, including presentation after cardiac arrest. OBJECTIVES: The aim of this study was to develop and validate a parsimonious patient-level clinical risk model of in-hospital mortality for contemporary patients with acute myocardial infarction. METHODS: Patient characteristics at the time of presentation in the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-GWTG (Get With the Guidelines) database from January 2012 through December 2013 were used to develop a multivariate hierarchical logistic regression model predicting in-hospital mortality. The population (243,440 patients from 655 hospitals) was divided into a 60% sample for model derivation, with the remaining 40% used for model validation. A simplified risk score was created to enable prospective risk stratification in clinical care. RESULTS: The in-hospital mortality rate was 4.6%. Age, heart rate, systolic blood pressure, presentation after cardiac arrest, presentation in cardiogenic shock, presentation in heart failure, presentation with ST-segment elevation myocardial infarction, creatinine clearance, and troponin ratio were all independently associated with in-hospital mortality. The C statistic was 0.88, with good calibration. The model performed well in subgroups based on age; sex; race; transfer status; and the presence of diabetes mellitus, renal dysfunction, cardiac arrest, cardiogenic shock, and ST-segment elevation myocardial infarction. Observed mortality rates varied substantially across risk groups, ranging from 0.4% in the lowest risk group (score <30) to 49.5% in the highest risk group (score >59). CONCLUSIONS: This parsimonious risk model for in-hospital mortality is a valid instrument for risk adjustment and risk stratification in contemporary patients with acute myocardial infarction.
BACKGROUND: As a foundation for quality improvement, assessing clinical outcomes across hospitals requires appropriate risk adjustment to account for differences in patient case mix, including presentation after cardiac arrest. OBJECTIVES: The aim of this study was to develop and validate a parsimonious patient-level clinical risk model of in-hospital mortality for contemporary patients with acute myocardial infarction. METHODS:Patient characteristics at the time of presentation in the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-GWTG (Get With the Guidelines) database from January 2012 through December 2013 were used to develop a multivariate hierarchical logistic regression model predicting in-hospital mortality. The population (243,440 patients from 655 hospitals) was divided into a 60% sample for model derivation, with the remaining 40% used for model validation. A simplified risk score was created to enable prospective risk stratification in clinical care. RESULTS: The in-hospital mortality rate was 4.6%. Age, heart rate, systolic blood pressure, presentation after cardiac arrest, presentation in cardiogenic shock, presentation in heart failure, presentation with ST-segment elevation myocardial infarction, creatinine clearance, and troponin ratio were all independently associated with in-hospital mortality. The C statistic was 0.88, with good calibration. The model performed well in subgroups based on age; sex; race; transfer status; and the presence of diabetes mellitus, renal dysfunction, cardiac arrest, cardiogenic shock, and ST-segment elevation myocardial infarction. Observed mortality rates varied substantially across risk groups, ranging from 0.4% in the lowest risk group (score <30) to 49.5% in the highest risk group (score >59). CONCLUSIONS: This parsimonious risk model for in-hospital mortality is a valid instrument for risk adjustment and risk stratification in contemporary patients with acute myocardial infarction.
Authors: Leah L Zullig; Shelley A Jazowski; Tracy Y Wang; Anne Hellkamp; Daniel Wojdyla; Laine Thomas; Lisa Egbuonu-Davis; Anne Beal; Hayden B Bosworth Journal: Health Serv Res Date: 2019-08-20 Impact factor: 3.402
Authors: Edward D Coverstone; Richard G Bach; LiShiun Chen; Laura J Bierut; Allie Y Li; Petra A Lenzini; Heidi C O'Neill; John A Spertus; Carmen C Sucharov; Jerry A Stitzel; Joel D Schilling; Sharon Cresci Journal: Basic Res Cardiol Date: 2018-08-10 Impact factor: 17.165
Authors: Oladipupo Olafiranye; Adetola Ladejobi; Max Wayne; Christian Martin-Gill; Andrew D Althouse; Michael S Sharbaugh; Francis X Guyette; Steven E Reis; John A Kellum; Catalin Toma Journal: J Interv Cardiol Date: 2016-11-04 Impact factor: 2.279
Authors: Friedrich Felix Hoyer; Kamila Naxerova; Maximilian J Schloss; Maarten Hulsmans; Anil V Nair; Partha Dutta; David M Calcagno; Fanny Herisson; Atsushi Anzai; Yuan Sun; Gregory Wojtkiewicz; David Rohde; Vanessa Frodermann; Katrien Vandoorne; Gabriel Courties; Yoshiko Iwamoto; Christopher S Garris; David L Williams; Sylvie Breton; Dennis Brown; Michael Whalen; Peter Libby; Mikael J Pittet; Kevin R King; Ralph Weissleder; Filip K Swirski; Matthias Nahrendorf Journal: Immunity Date: 2019-11-12 Impact factor: 31.745
Authors: Cian McCarthy; Sean Murphy; Joshua A Cohen; Saad Rehman; Maeve Jones-O'Connor; David S Olshan; Avinainder Singh; Muthiah Vaduganathan; James L Januzzi; Jason H Wasfy Journal: JAMA Cardiol Date: 2019-05-01 Impact factor: 14.676